Malosa Medical
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Malosa Medical - overview
Location
Halifax, England, UK
Primary Industry
Medical Devices & Equipment
About
Malosa Medical is a UK-based company specializing in innovative ophthalmic products that cater to various eye-related conditions, enhancing patient care and supporting healthcare professionals through advanced solutions. Malosa Medical focuses on providing ophthalmic solutions, with headquarters located in Halifax, UK. The company was acquired by Beaver-Visitec International, a portfolio company of TPG, in April 2017. Isabel Malosa serves as the CEO, showcasing her leadership in the ophthalmic field.
Malosa Medical specializes in a comprehensive portfolio of ophthalmic products aimed at addressing cataracts, glaucoma, and retinal diseases. Their offerings include surgical instruments and intraocular lenses for cataract procedures, glaucoma treatment solutions, and quality accessories for various ophthalmic procedures, designed to meet healthcare professionals' needs and improve patient care through innovative technologies. In the most recent year, Malosa Medical reported a revenue of USD 0. 00 and an EBITDA of USD -1,243.
90. Revenue is generated through direct sales of ophthalmic products to healthcare facilities and surgical centers, focusing on B2B sales for surgical instruments and consumables. Malosa Medical aims to expand its product range and enter new geographic markets. Following its acquisition in April 2017, the company is focusing on developing new ophthalmic products, with plans to launch them in the coming years.
The funding from this acquisition will support these initiatives, enabling the company to enhance its product offerings and expand into additional markets.
Current Investors
BVI Medical, Inc.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.malosa.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Malosa Medical - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 8,210,489 | 8,892,715 | 10,725,000 | 12,486,000 | 11,682,000 | - | - | - | - | - |
| % Revenue Growth (YoY) | - | 8.3% | 20.6% | 16.4% | (6.4%) | (100.0%) | - | - | - | - |
| EBITDA (USD) | 2,097,696 | 1,871,555 | 1,850,000 | 1,308,000 | 2,608,000 | (47,000) | (15,000) | - | - | - |
| Operating Income (USD) | 1,908,814 | 1,634,707 | 1,505,000 | 1,078,000 | 2,607,000 | (47,000) | (15,000) | - | - | - |
| Operating Margin | 23.2% | 18.4% | 14.0% | 8.6% | 22.3% | - | - | - | - | - |
| % EBITDA Margin | 25.5% | 21.0% | 17.2% | 10.5% | 22.3% | - | - | - | - | - |
| NET Income (USD) | 1,470,457 | 1,128,879 | 1,099,000 | 869,000 | 2,239,000 | (273,000) | (28,000) | - | - | - |
| % Net Margin | 17.9% | 12.7% | 10.2% | 7.0% | 19.2% | - | - | - | - | - |
Malosa Medical - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Malosa Medical | - |
Displaying 1 - 1 of 1
Malosa Medical - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.